Lululemon: Don't Give Up On It Yet

Lululemon's stock has plummeted 52% in seven months of 2025, significantly underperforming peers, driven by concerns over a cautious US consumer, decelerating growth in China, and an expected 110 basis point reduction in gross margins due to tariffs and competition from 'dupes.' Despite these headwinds, the stock's valuation is now historically cheap at 13.53x blended earnings. Analysts point to potential catalysts including management's tariff mitigation efforts, ongoing litigation against knockoffs, improving US-China trade dialogue, and recent insider and Michael Burry investments, suggesting that current risks may be largely priced in and warranting a speculative buy rating.

Analysis

Lululemon's stock has experienced a dramatic 52% price decline in the first seven months of 2025, significantly underperforming the S&P 500's 6.9% gain and outpacing the declines of competitors like Adidas. This sell-off is rooted in several fundamental concerns, including acknowledged consumer caution in the Americas and decelerating, albeit still strong, revenue growth in China, which slowed from 38% in Q4 2024 to 22% in Q1 2025. Margin pressure is a primary headwind, with management forecasting a 110 basis point decrease in gross margin for 2025, driven by increased tariffs and higher markdowns. The company's brand moat is also being tested by the growing consumer acceptance of lower-priced "dupes," prompting litigation against competitors like Costco. Despite these risks, the stock's valuation has compressed to a historically low 13.53 times blended earnings. This is juxtaposed against a strong balance sheet with $1.3 billion in cash, significant long-term growth in revenue and earnings, and notable contrarian signals such as recent insider purchases totaling $1.5 million and a new, substantial position taken by value investor Michael Burry.

Key Decisions for Investors

• Given the stock's historically low valuation and the fact that significant risks appear priced in, investors with a higher risk tolerance could consider initiating a speculative position, noting the author's fair value estimate of $220.46 provides a modest margin of safety.
• Closely monitor gross margin performance and management's commentary on tariff mitigation efforts in the second half of the year, as sustained margin compression would validate the bear case, while stabilization could serve as a key re-rating catalyst.
• Treat the recent insider buying and the new position by a prominent value investor as a strong contrarian signal, potentially justifying a tactical allocation despite the negative market sentiment and decelerating growth outlook.
• Investors should track developments in US-China trade relations and the results of litigation against competitors, as positive outcomes in these areas could alleviate major headwinds and improve the company's medium-term earnings power.